Helisinki Pharmaceuticals Private Limited
About Helisinki Pharmaceuticals Private Limited
Data last updated:
Helisinki Pharmaceuticals Private Limited is a private limited company based in Karnal, Haryana, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 12 August 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24233HR2014PTC053069. Its GSTIN is 06AAECH2933C1Z1 (Haryana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Amita and Amit Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 195/4 Moti Nagar, Karnal, Haryana, India – 132001.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.46 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹2,396 (net margin 0%) and EBITDA of ₹4.3 Lakh (EBITDA margin 2.9%). Revenue has grown at a compounded annual rate (CAGR) of 25% over three years and 15% over five years.
As per MCA filings, the company has open charges of ₹1 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Helisinki Pharmaceuticals Private Limited's registered office is in Karnal, Haryana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address195/4 Moti Nagar, Karnal, Haryana, India – 132001
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Helisinki Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Helisinki Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Helisinki Pharmaceuticals Private Limited, buy the company report.
Financials of Helisinki Pharmaceuticals Private Limited
FY 2025 filings availableHelisinki Pharmaceuticals Private Limited reported revenue of ₹1.46 Cr (up 14% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 15% over five years, including 14% growth in the latest year. EBITDA rose 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.3 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2,396 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.9% | ||||
| Net Profit Margin | 0% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Helisinki Pharmaceuticals Private Limited, buy the company report.
Board of directors of Helisinki Pharmaceuticals Private Limited
Helisinki Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amita | Director | 12 Aug 2014 | 12 Years 2 Months | Current |
| Amit Kumar | Director | 12 Aug 2014 | 12 Years 2 Months | Current |
Peer comparison
Helisinki Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Isocratic Pharmaceuticals Private Limited | ₹1.47 Cr (FY 2025) | Ahmedabad, Gujarat, India | ||||
| Strimed Pharmaceuticals Private Limited | ₹1.47 Cr (FY 2025) | 13.0% | Mumbai, Maharashtra, India | |||
| Sthree Pharmaceuticals Private Limited | ₹1.46 Cr (FY 2024) | -69.0% | Chennai, Tamil Nadu, India | |||
| Stevia Pharmaceuticals Private Limited | ₹1.46 Cr (FY 2025) | -8.0% | Secunderabad, Telangana, India | |||
| Helisinki Pharmaceuticals Private Limitedthis company | ₹1.46 Cr (FY 2024) | ₹2,396 | 0% | 14.0% | Karnal, Haryana, India | |
| Trulay Pharmaceuticals Private Limited | ₹1.46 Cr (FY 2024) | -23.0% | Rajkot, Gujarat, India | |||
| Zoetic Pharmaceuticals Private Limited | ₹1.46 Cr (FY 2024) | 3.0% | Uttar Pradesh, India | |||
| Adura Pharmaceuticals Private Limited | ₹1.45 Cr (FY 2024) | 62.0% | Zirakpur, Punjab, India |
To see the full peer comparison of Helisinki Pharmaceuticals Private Limited, buy the company report.
Auditor
Helisinki Pharmaceuticals Private Limited is audited by AMIT VED & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AMIT VED & ASSOCIATES | FY 2017 | 019057N |
Shareholding
The shareholding of Helisinki Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Helisinki Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Oct 2025 | 101187641 | Others | ₹90 Lakh | Open | |
| 08 Jul 2019 | 100279404 | Others | ₹10 Lakh | Open |
To see the full charge records of Helisinki Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Helisinki Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Helisinki Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Helisinki Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAECH2933C1Z1 | Haryana | Active | 14 Dec 2017 |
To see the full GST registrations and return filing status of Helisinki Pharmaceuticals Private Limited, buy the company report.
Recent activity
Helisinki Pharmaceuticals Private Limited has 2 board changes on record since 2014: 2 appointments. The latest: Amit Kumar was appointed as Director on 12 Aug 2014.
Frequently asked questions
Helisinki Pharmaceuticals is an active private limited company based in Karnal, Haryana, India. The company works in other wholesale, within the trading industry. It was incorporated on 12 August 2014 (12+ years old) and is registered under CIN U24233HR2014PTC053069.
Helisinki Pharmaceuticals has 2 current directors:
- Amita - Director
- Amit Kumar - Director
The latest financial statements of Helisinki Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Helisinki Pharmaceuticals is 06AAECH2933C1Z1, registered in Haryana.
The CIN (Corporate Identification Number) of Helisinki Pharmaceuticals is U24233HR2014PTC053069. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Helisinki Pharmaceuticals was incorporated on 12 August 2014, making it 12+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Helisinki Pharmaceuticals by revenue are Isocratic Pharmaceuticals Private Limited, Strimed Pharmaceuticals Private Limited, Sthree Pharmaceuticals Private Limited, Stevia Pharmaceuticals Private Limited, Trulay Pharmaceuticals Private Limited and 2 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Amit Kumar was appointed as Director on 12 Aug 2014. Amita was appointed as Director on 12 Aug 2014.
The registered office of Helisinki Pharmaceuticals is at 1954 Moti Nagar, Karnal, Haryana, India – 132001.
Helisinki Pharmaceuticals operates in the trading industry, in the other wholesale segment.
Helisinki Pharmaceuticals has open charges of ₹1 Cr and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
